Clinical Trials

CCA supports research through encouraging members to participate in clinical trials, advertised in our member magazine and here on our website. Trials range from drug therapy and dietary investigations, to population surveys to discover commonality and genetic predisposition.

Current research

For a comprehensive search of all Australian clinical trials visit:

  • Why are clinical trials necessary?

    Clinical trials of new medications and studies present an opportunity for pharmaceutical and biotechnology companies to ascertain the safety and effectiveness of their medications; for physicians to find new medications to help their patients; and for people with IBD to actively participate to assist their health and search for treatments for these diseases.

  • CCA's role

    CCA plays an important role in bringing trials to the attention of potential participants, via sources such as its website. People who wish to participate in a trial should discuss the opportunity with their treating doctor. We also have details of some closed IBD studies. Please note that evaluating data from clinical trials is a lengthy process. We will publish results once they are made available to CCA. Thank you for your patience.

    CCA does not endorse or ensure the scientific merit of trials advertised on our website or in our publications.

  • Clinical trials and patients' rights

    Patients enrolled in a trial are closely monitored throughout the trial by the clinical investigators. On the first visit, the patient can and should prepare a list of questions and any concerns, to ask the investigator and nurse.

  • Questions to ask

    Questions to ask may include:

    • What are the advantages and disadvantages of taking part in this trial?
    • What is the purpose of the trial and how long will it last?
    • Who has reviewed the trial and approved the trial?
    • What kind of tests, procedures and treatments are involved?
    • How often would I require follow up tests etc?
    • What are the side effects of the treatment?
    • Will there be any pain or discomfort?
    • Is the treatment in the form of a pill or injection?
    • Will the treatment be free?
    • When the trial is finished, if I respond, can I still continue on with the treatment if I need to?
    • How many visits to the centre are involved?
    • If I am harmed during the trial, what treatment would I be entitled to?
    • What are my treatment options, other than this medication?
    • Who do I call if I experience a side effect during the trial?
    • Will my personal doctor receive progress reports?
    • If I don’t understand some of the informed consent information, who do I call?
    • Who is the sponsor of the trial?